Intranasal Anti-Cd3 Mab Treatment Showed A Reduction In Intracerebral Hemorrhage Injury Severity

Tiziana Life Sciences

27/04/2023 12:15

April 27 (Reuters) - Tiziana Life Sciences Ltd  TLSA.O :
    * TIZIANA LIFE SCIENCES LTD - INTRANASAL ANTI-CD3 MAB
TREATMENT
SHOWED A REDUCTION IN INTRACEREBRAL HEMORRHAGE INJURY SEVERITY

Source text for Eikon:  ID:nGNX6N1l3T 
Further company coverage:  TLSA.O 

 (Reporting by Siddarth S)
 ((Siddarth.s@thomsonreuters.com;))